product:AN2025(buparlisib, pan-P13K inhibiter)
Indications:HNSCC
ClinicalTrials.gov Identifier: NCT04338399
product:AN0025(EP4 Antagonist)
Indications:Solid Tumors
ClinicalTrials.gov Identifier: NCT04432857
product:AN0025(EP4 Antagonist)
Indications:Rectal Cancer
ClinicalTrials.gov Identifier: NCT03152370
product:AN1004 ( pelareorep)
Indications:Advanced/ Metastatic Breast Cancer
Chinadrugtrials.org.cn:CTR20201625